This article explores the development and validation of a new enzyme-linked immunosorbent assay (ELISA) with high sensitivity and selectivity for bioanalysis of bevacizumab (BEV), a monoclonal ...
The enzyme-linked immunosorbent assay (ELISA) is a staple in many laboratories. While relatively simple in theory, there is significant room for errors that can cause ambiguous and inconsistent ...
COVID-19 has thrown ELISA testing into the spotlight and driven advances in technology allowing the process to become quicker and more accurate. While there are limits to ELISA antibody tests’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results